Acquirer · Corporate
Mankind Pharma
1Undisclosed—0
Photo: MMVODV / Wikimedia Commons, CC BY-SA 4.0Mankind Pharma to buy 70% of Belgian CAR-T biotech Armed Cell Therapeutics for €48M
The Indian drugmaker is making its first move into advanced cancer cell therapy. Armed Cell Therapeutics, chaired by former Johnson & Johnson science chief Paul Stoffels, is developing CAR-T treatments for lymphoma and small cell lung cancer.
Undisclosedn/aStage n/aCorporate
Latest in Mankind Pharma
All Mankind Pharma exitsOpen tracker →
Mankind Pharma → Armed Cell TherapeuticsUndisclosedUndisclosed